Ambulatory BP most cost effective for diagnosis of hypertension Clinical study 13 June 2020 Pages: 2 - 2
Budget impact of avapritinib for unresectable or metastatic GIST in a US health plan Meeting report 13 June 2020 Pages: 4 - 4
Cost effectiveness of blinatumomab for relapsed or refractory ALL highlighted at ISPOR Meeting report 13 June 2020 Pages: 7 - 8
Cost effectiveness of HPV vaccination and screening in LMICs Clinical study 13 June 2020 Pages: 8 - 8
Economic evaluations of fidaxomicin for Clostridium difficile infection Meeting report 13 June 2020 Pages: 11 - 11
Evidence-based guidelines for paediatric gastroenteritis reduce costs Clinical study 13 June 2020 Pages: 12 - 12
Extracoporeal photophoresis cost effective in cutaneous T-cell lymphoma Meeting report 13 June 2020 Pages: 13 - 13
Falls prevention strategy among high-risk elderly effective, cost saving Clinical study 13 June 2020 Pages: 14 - 14
Financial ties "extensive" between leaders of US medical societies and industry News item 13 June 2020 Pages: 15 - 15
Healthcare costs differ for metastatic castration-resistant prostate cancer Clinical study 13 June 2020 Pages: 16 - 16
Hepatoblastoma screening of low-birthweight children cost effective in US Clinical study 13 June 2020 Pages: 17 - 17
High out-of-pocket cost burden for insulin in privately insured US patients Clinical study 13 June 2020 Pages: 18 - 18
High out-of-pocket spend among privately insured US patients with T1DM Clinical study 13 June 2020 Pages: 19 - 19
Inclusion of boys for HPV vaccination cost effective in the Netherlands Clinical study 13 June 2020 Pages: 20 - 20
Is extended ECG monitoring for AF following stroke cost effective? Review 13 June 2020 Pages: 21 - 21
Mepolizumab in severe eosinophilic asthma reduces healthcare use Meeting report 13 June 2020 Pages: 22 - 22
New oral anticoagulants cost effectiveness unlikely in chemotherapy Clinical study 13 June 2020 Pages: 23 - 23
Progressive fibrosing interstitial lung disease: high care needs, high costs Clinical study 13 June 2020 Pages: 25 - 25
Ribociclib for HR+/HER2- ABC: cost effective in Canada or USA? Meeting report 13 June 2020 Pages: 26 - 26
SAE-related costs lower with larotrectinib than with entrectinib Meeting report 13 June 2020 Pages: 27 - 27
Use of aprepitant for chemotherapy-induced nausea/vomiting saves cost Clinical study 13 June 2020 Pages: 29 - 29
Variability in ED throughput times for patients in observation status costly Clinical study 13 June 2020 Pages: 31 - 31
WTP for prevention of childhood overweight and obesity decreases Clinical study 13 June 2020 Pages: 33 - 33
NZ PHARMAC to fund Creon Micro for children with cystic fibrosis News item 13 June 2020 Pages: 35 - 35